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The physiological environment of the intestine is characterized by its variegated
composition, numerous functions and unique dynamic conditions, making it challenging
to recreate the organ in vitro. This review outlines the requirements for engineering
physiologically relevant intestinal in vitro models, mainly focusing on the importance of
the mechano-structural cues that are often neglected in classic cell culture systems.
More precisely: the topography, motility and flow present in the intestinal epithelium.
After defining quantitative descriptors for these features, we describe the current state
of the art, citing relevant approaches used to address one (or more) of the elements
in question, pursuing a progressive conceptual construction of an “ideal” biomimetic
intestinal model. The review concludes with a critical assessment of the currently available
methods to summarize the important features of the intestinal tissue in the light of their
different applications.
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INTRODUCTION
The study of intestinal phenomena, as well as intestinal disorders, has been empowered by the use of
animal models. However, many intestinal processes are difficult to control using in vivomodels. In
vitro models are employed to facilitate the study of complex in vivo phenomena in a simplified
context, allowing well-controlled and repeatable conditions for the evaluation of cell response.
They can be used in many different fields thanks to their wide areas of application including
toxicology, drug testing, tissue engineering and nutraceutics (Mattei et al., 2014). Moreover, in
vitro intestinal models can potentially enable improved studies of cellular growth and proliferation,
drug absorption, and host-microbial interactions, while reducing the expense and ethical issues
associated with the use of animal experiments (Cencicˇ and Langerholc, 2010). In this context,
current guidelines and legislation on the use of animals in science adhere to the “3Rs” principles,
defined by Russell and Burch (1959); Guidelines for the treatment of animals in behavioural
research teaching (1997). The 3Rs are based on a humane approach to scientific experimentation
and aim to: ‘Replace” animals used in experiments with non-sentient alternatives; “Reduce” the
number of animals employed; and “Refine” animal experiments so that they cause minimum pain
and distress.
The physiological environment of the intestine is characterized by its variegated composition,
numerous functions and unique dynamic conditions. It is the organ responsible for the digestion
and absorption of nutrients, but it also has secretory and immune functions (DeWitt and Kudsk,
1999; Santos and Perdue, 2000; Jaladanki and Wang, 2011). The intestinal epithelium, the most
external layer of the mucosa, is the most self-renewing tissue of adult mammals and it includes
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different cell types, each of them specialized in a different
function: enteroendocrine cells, Paneth cells, goblet cells,
enterocytes, and microfold (M) cells (Crosnier et al., 2006).
Roughly 90% of the absorption in the digestive tract happens
in the small intestine (Balimane and Chong, 2005), since its
epithelium folds into microscopic highly vascular finger-like
projections, called villi. Besides providing an increase in the
area available for the absorption of nutrients, the crypt-villus
architecture is determinant in the migration of the intestinal
epithelial cells as they differentiate (Heath, 1996). Moreover,
the functions of the gut rely on the motility of its different
parts. The motion itself has important functions, such has
mixing, propulsion, and separation of luminal contents, that
are the result of the coordinated interaction of excitatory and
inhibitory neurons of the enteric nervous system (Chang and
Leung, 2014). Additionally, the intestine is also where commensal
microbes mainly live and interact with gut lymphoid tissues and
the host immune system, which strongly influences intestinal
homeostasis (Round and Mazmanian, 2009). The features
of the intestinal epithelium’s environment are schematically
represented in Figure 1.
It is widely accepted that cell differentiation and proliferation
are dictated by a combination of not only chemical, but also
mechanical cues. Studies have demonstrated that mechanical
factors, including mechanical forces, substrate stiffness,
nanotopography of the adhesion surface and fluid flow can guide
stem cell fate (Mousavi and Hamdy Doweidar, 2015). Likewise,
the mechanical cues to which the intestinal epithelium is
exposed should not be disregarded when developing a predictive
intestinal model. Epithelial cells have exceptional interactions
with their microenvironment, being subject to biomechanical
and cues biochemical that determine cell fate and even contribute
to pathological processes (Helmlinger et al., 1997; Farge, 2003;
Keller et al., 2003; Brancaccio et al., 2006). This phenomenon is
defined as mechanotransduction, i.e., how cells sense physical
forces and then translate them into biological responses (Paluch
et al., 2015). In recent decades much effort has been dedicated to
understanding the mechanisms regulating mechanotransduction
as manifested by the interest in providing mechanical stimuli to
in vitro cell cultures.
One of the challenges of science fields relying on experimental
cell biology and tissue engineering is the development of methods
and strategies for implementing physiologically relevant in vitro
models in order to better mimic tissue or organ responses.
Before designing experiments, scientists must select appropriate
culture conditions, define cell numbers and assess the tools
available for creating appropriate in vitro models capable of
answering the research questions posed. Some key parameters
for the design of biomimetic in vitro intestinal models will be
discussed in this review. To this end, we will start by defining
the design specifications for an intestinal in vitro system. What
does constitute an ideal intestinal model from an engineer’s point
of view?
An ideal in vitro model recapitulates all the essential
features of the biological counterpart it is intended to
represent. Considering the microenvironment of the intestine
and examining the dynamic conditions to which epithelial
intestinal cells are exposed, the ideal engineered human intestinal
in vitro model (for healthy tissue) should contain the following
features (summarized in Table 1):
- human-derived cells from all types representative of the native
gut epithelium (ideally, also from all the layers of the mucosa)
with the ability of being cultured for the defined assay time
without losing their characteristics;
- a substratum with a 3D structure [villi-like and crypt
structures, where the villi present a surface density of 10–40
mm2 and have a height between 0.5 and 1mm (Hasan and
Ferguson, 1981; Standring, 2016)] and similar properties to the
native lamina propria in terms of its chemical composition and
biomechanical behavior [elastic modulus around 0.5–1 kPa
(Stidham et al., 2011; Stewart et al., 2018)];
- a fluidic system that provides adequate oxygenation and
nutrients to the cell medium, as well as physiological shear
stress [around 0.0002–0.008 Pa (Kim et al., 2012)];
- a flexible substrate to provide cycle deformation to the
epithelium [around 8–10% strains at 0.15Hz (Kim et al., 2012;
Cei et al., 2016)];
- a biochemical environment that comprises the
epithelium/immune system crosstalk (Araujo et al., 2016) and,
of great importance, the microbiota of the gut [the approaches
developed to address this last aspect are reviewed elsewhere
(Wang et al., 2018)];
Is it possible to recreate all these features in vitro?
In an attempt to answer this question, this review is aimed at
presenting the current methodologies used to develop intestinal
in vitro models: from the most simplistic and traditional cell
monolayer to the complex dynamic 3D models developed
with the aid of engineered systems. The organization and
discussion of the following contents reflect our critical view
of the different solutions and their applications from a bio-
engineering perspective.
CELLS
The intestinal epithelium is a tissue of particular interest as it is in
constant cell renewal from the stem cells of the crypts. The crypts,
together with the fibroblasts of the mucosa, form a niche of
pluripotent stem cells that generate the main cell types—of which
enterocytes are the most predominant. The phenomena which
determine phenotype commitment and cell-specific expressions
are not fully understood, thus the field attracts intense biological
investigations (Simon-Assmann et al., 2007; Noah et al., 2011;
Clevers and Batlle, 2013).
Inevitably, the cellular composition of any in vitromodel is the
main determinant of its outcomes. Choosing the cells to represent
the human intestine outside of its physiological environment
dictates the classification and applications of the in vitro model,
as described in this section.
The “What’s Good Lasts Forever” Choice:
Immortalized Cell Lines
Caco-2 cells are the most widely used cell model to study the
permeability of drugs over the last 20 years. There are other
cell lines that were reported to constitute intestinal in vitro
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 2 June 2019 | Volume 7 | Article 144
Costa and Ahluwalia Intestinal in vitro Model Engineering
FIGURE 1 | Key elements of the intestinal microenvironment.
TABLE 1 | Summary of some physiologically relevant parameters characteristic of
the intestinal epithelium microenvironment.
Stiffness Shear stress Strain Villi
0.5–1 kPa 0.0002–0.008Pa 8–10% at 0.15Hz Density: 10–40 mm2;
Height: 0.5–1 mm
models [reviewed in (Simon-Assmann et al., 2007)], but the
Caco-2 line has been accepted as standard for prediction of drug
intestinal permeability in humans by pharmaceutical companies
and regulatory authorities (Hidalgo et al., 1989; Hilgers et al.,
1990). They are an immortal human cell line derived from a
human colorectal adenocarcinoma that is regularly used in the
models of the intestinal epithelium. When in culture, they grow
into a confluent monolayer and then differentiate, adopting a
behavior very similar to enterocytes (Smetanová et al., 2011).
Caco-2 cell differentiation starts when the cells achieve
confluence, around 7 days after seeding and is completed within
21 days. That is when the cells are polarized and connected
to each other through tight junctions, exhibiting an apical
brush border structure with the expression of several enzymes,
transporters and receptors (Antunes et al., 2013a).
Nevertheless, the Caco-2 monoculture does not contemplate
other important factors that influence the functionality of
enterocytes such as the mucus layer or the interactions between
the epithelium and the stroma (Li et al., 2013), pushing scientists
to develop more complex cellular models. Furthermore, in
different perspective, the most widely accepted cell culture
protocol requires about 3 weeks, which can be labor intensive and
time consuming, limiting its wide application in high-throughput
screening of new compounds (Cai et al., 2014). Addressing this,
some groups have developed modified Caco-2 culture techniques
that require a shorter culturing period (Chong et al., 1997;
Lentz et al., 2000; Sevin et al., 2013) by changing experimental
conditions such as the medium composition and seeding density
(Cai et al., 2014). Interestingly, the presence of flow consistently
accelerates Caco-2 differentiation and barrier formation (Kim
et al., 2012; Giusti et al., 2014; Cacopardo et al., 2019).
As a further improvement, a cell model consisting of a
co-culture of Caco-2 and mucus producing HT29 cell lines
was developed. It mimics both enterocytes and goblet cells,
and it was reported to generate more predictable experimental
results, due to the role of mucus on drug transport (Pontier
et al., 2001; Mahler et al., 2009; Pereira et al., 2015b). Other
models were developed to include the presence of M-cell-
like cells that resemble the intestinal M cell—characterized
by few irregular microvilli and elevated transcytotic activity
(Clark et al., 2001; Araujo et al., 2016). Some researchers
have also reported that Raji B cells can promote M cell
phenotype in some Caco-2 cells (Kerneis, 1997; Gullberg et al.,
2000; Araújo and Sarmento, 2013). Based on the rationale
behind these two previous models, Sarmento’s group developed
a triple co-culture model (Caco-2, HT29-MTX and Raji B)
that was able to induce the M cells phenotype in some cells
and, additionally, to provide a higher transport of insulin
(Antunes et al., 2013b; Araújo and Sarmento, 2013).
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The “Live Fast and Die Young” Choice:
Primary Cells
As already mentioned, ideally, an in vitro model that closely
resembles the human intestinal epithelium should comprise a
combination of the different gastro intestinal (GI) epithelial cells
able to be cultured for long periods.
Several attempts have been made to isolate and expand viable
intestinal epithelium in in vitro cultures from human tissues.
For instance, Lahar et al. (2011) developed a protocol that
required various growth factors as well as the intimate interaction
between the intestinal epithelial cells intestinal and sub-epithelial
myofibroblasts (ISEMFs) to sustain epithelial growth in vitro
and in vivo. Aldhous et al. obtained intestinal epithelial cells
from duodenal biopsies together with Lamina propria (LP)
cells. The epithelial cells were cultured on collagen membranes
on top of LP cells and allogeneic Epstein-Barr Virus (EBV)-
transformed B lymphocytes, in a 12-well tissue culture set-up
(Aldhous et al., 2001).
In spite of all the efforts, a reproducible protocol for
maintaining long term primary cell cultures from intestinal tissue
samples remains a challenge (Lukovac and Roeselers, 2015),
despite the fact that organoid technology has somewhat modified
the research landscape.
The “I Want It All” Choice: Intestinal
Organoids or Mini-Guts
In 2007, the identification of intestinal stem cells - the Lgr5
stem cells of the small intestinal and colonic crypts by Clevers
and co-workers came as a “game changer” (Barker et al., 2007).
Since these cells can differentiate into all intestinal epithelial cells
(including also stem and progenitor cells), they can be grown in
vitro, for longer periods, forming the so called “mini guts,” or
organoids (Sato et al., 2009, 2011). These intestinal organoids are
self-organized in 3D structures that recapitulate major features
of native tissue, exhibiting a highly folded epithelium structure
consisting of crypts and villi, just like the native intestinal
epithelium. The organoid, illustrated in Figure 2, is composed
of a central hollow region and several protruding structures.
The external parts resemble the crypt structure of the small
intestine, with Lgr5+ stem cells and Paneth cells in the apex
region, while the central sphere consists mainly of differentiated
cells (Nakamura and Sato, 2018). The obvious potential of these
“self-sufficient” organoids in the field of regenerative medicine
was instantly clear and the “mini guts” were successfully tested
for engraftment in mice (Shaker and Rubin, 2012; Liu et al.,
2016). The use of organoids is a fast growing field and it has
been explored for other applications ranging from regenerative
medicine (Wiegerinck et al., 2014) to host-microbe interaction
studies (Lukovac et al., 2014) and from drug testing to disease
modeling (Baumann, 2017). Nevertheless, organoids also have
their shortcomings. Specifically, by themselves they are unable
to mimic the biomechanical forces that stem cells are exposed
to in vivo. Furthermore, since they are heterogeneous in terms
of shape, size and viability and their 3D spatial arrangement
limits drug penetration, they are usually unsuitable for drug
screens (Fatehullah et al., 2016; Yin et al., 2016) and permeability
FIGURE 2 | Illustrative scheme of a gut organoid.
studies. Remarkably, to overcome this issue some groups have
developed enteroid monolayers, which are epithelial cells derived
from the same Lgr5 stem cells but organized in 2D. These
monolayers provide a structure for the basolateral addition of
other cell types, such as immune cells or pathogens, and to study
specific responses to different apical stimuli (Ettayebi et al., 2016;
Braverman and Yilmaz, 2018). In such systems of course, the
importance of a three-dimensional structure to better mimic the
native tissue is neglected in favor of the desired application of the
model—this is an aspect that will be discussed further ahead.
3D ARCHITECTURE
One of the most common systems used to recreate in vitro the
intestinal interface is the Transwell R©, represented in Figure 3. It
has been used to study intestinal permeability of drugs, toxins
or microorganisms. Here, the epithelial cells are seeded on a
membrane housed on a “transwell insert.” The insert separates
the apical compartment, corresponding to the intestinal lumen,
from the basal one - which represents the blood vessels. This
system mimics the barrier configuration of the in vivo intestine
to a certain extent (Pereira et al., 2015b).
Themodels based on the Transwell R© system benefit from high
standardization and ease of use but they might be considered
too reductionist. Certainly, most of the current understanding of
many biological processes is based on studies conducted on two-
dimensional (2D) monolayer-monotypic cultures, however cells
in vivo exist in a 3D heterogeneous and complex environment
which regulates cell activity. The intricate array of biochemical
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signals is controlled by the different cells as they produce
and absorb molecules to/from each other and to/from the
extracellular environment. 2D models lack the representation of
these interactions and are a “reductionist approach” that does not
properly represent the in vivo scenario. Therefore, 3D models
are now considered as a means to bridge the gap between cells
cultures and animal models (Pampaloni et al., 2007; Mattei
et al., 2014). Figure 4 summarizes how we classify the methods
employed for obtaining 3D models of the intestine, which will
be described in the following sections. One can develop co-
cultures organized in multilayers, where cells are deposited in
different sheets, often embedded in an ECM-like substrate (such
as Matrigel R© or hydrogels). Alternatively, one can choose to use
scaffolds. In general, the scaffolds obtained using biofabrication
techniques are designed tomimic (or induce) either the villi/crypt
architecture of the epithelium or the tube-like structure of the gut.
Leveling Up: Multilayer Models
In recognition of the importance of matrix dimensionality, there
has been a gradual shift from 2D monolayer cell cultures to 3D
models. The multilayer models are a first step in this direction.
Addressing the importance of stromal cells and extracellular
matrix (ECM) in the homeostasis of intestinal epithelial cells
(Powell et al., 2005), a couple of models were recently proposed
comprising Caco-2 and goblet-induced HT29-MTX cells and
stromal cells (Li et al., 2013; Pereira et al., 2015a) that better
recreate the composition of the tissue. Another example is
a co-culture system developed by Leonard and colleagues
to study the inflammation process. The model consisted of
a three-dimensional co-culture of human intestinal epithelial
cells and immunocompetent macrophages and dendritic cells,
which better recreate an increased inflammatory cytokine
response (Leonard et al., 2010). Note that despite having a 3D
rearrangement, and being thus more physiologically relevant,
these models still lack the characteristic crypt-villi architecture.
Cell Scaffolds: Sustaining the Idea of 3D
Besides organoids and multilayer models, the 3D structure is
commonly achieved using a scaffold. Scaffolds are engineered
structures that “aid” cells in organizing themselves similarly to
the in vivomicroenvironment.
Scaffolds can be fabricated in different ways and can be made
of different materials (Bitar and Raghavan, 2012). Biological
scaffolds derived from extracellular matrix (ECM) have been
developed as substrates for remodeling of different tissues,
including the gut. Small intestinal submucosa (SIS) scaffolds
were also employed for generating in vitro models of the small
intestine, particularly for their potential to induce stem cell
differentiation. In a study by Schweinlin et al. (2016), intestinal
organoids derived from intestinal crypts from healthy human
small intestine were seeded on a decellularized SIS scaffold,
in co-culture with fibroblasts. The organoids differentiated
into different intestinal cell types after 7 days (this in vitro
model also entailed the presence of medium flow as will
be described in section To See Is to Believe: Monitoring).
Again, using acellularized human tissue scaffold to culture
bone marrow stem cells, Patil and co-workers (Patil et al.,
2013) obtained differentiated epithelial cells and even reported
endothelial cells repopulating the blood vessels of the scaffold,
which also maintained its architecture with the villi intact and
structural proteins.
Villi-Like Structure
The recreation of the 3D architecture of the intestinal epithelium
has been the goal of numerous research groups. Some of them
have focused on the reconstruction of the villi architecture
FIGURE 4 | Summary of the different approaches used to develop 3D models
of the intestine.
FIGURE 3 | Representation of the Transwell® system.
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through biofabrication techniques. For instance, in 2011, Sung
et al. developed a 3D villi model consisting of a collagen
hydrogel scaffold. The authors obtained the scaffold by a
combination of laser ablation and sacrificial molding technique,
using calcium alginate, which allowed the maintenance of both
the complexity and integrity of the hydrogel structure. Evident
morphological similarities were observed between the collagen
scaffolds covered with the Caco-2 cells and the human jejunal
villi (Sung et al., 2011).
Later, to evaluate the integrity and the role of the 3D
model in predicting drug permeability, the same group adapted
the collagen scaffold to an insert design. Maintaining Caco-
2 cells on the scaffolds for 21 days did not shorten the villi,
and also promoted the formation of multiple layers caused by
cell penetration in the matrix as the collagen degraded. This
led to a higher permeability of the tested hydrophilic drug,
when compared with the data from 2D cultures, approximating
the values obtained for mammalian intestines. Moreover, they
reported that cell differentiation on the 3D scaffold varied along
the villus (Yu et al., 2012). The research activity of the group
led more recently to a comparative study on the absorptive and
metabolic properties of Caco-2 cells cultured in the collagen
hydrogel scaffolds and in monolayers. Cell growth was higher
in the 3D villi model and its barrier function was similar to the
in vivo scenario; the activity of the metabolic enzymes was also
improved in the 3D model (Yi et al., 2017). These collagen cell
scaffolds were also tested in amicrofluidic device, an aspect which
will be described in the next section (Shim et al., 2017).
Sharing the goal of mimicking the villi architecture, Costello
et al. developed a synthetic 3D scaffold able to support the co-
culture of epithelial cell types with selected bacterial populations.
The study was directed at exploring microbe-induced intestinal
disorders with the aim of developing targeted probiotic therapies.
Poly lactic-glycolic acid (PLGA) scaffolds, with villi shape, were
produced and seeded with Caco-2 cells. They were used as a
model to mimic the adhesion and invasion profiles of certain
bacteria species, as well as the therapeutic potential of two
probiotics. The authors found that the 3D environment affected
the probiotic action differently: while Lactobacillus was more
successful at dislocating pathogens, Escherichia coli Nissle was
more effective at hindering their adhesion (Costello et al., 2014b).
The same group employed the PLGA scaffolds to study cell
behavior and drug absorption of the Caco-2 and HT29-MTX
co-culture model. They observed that the two epithelial cell
types on the scaffolds were able to mimic the morphology
and differentiation profile verified in native intestinal tissue, as
identified by the expression of differentiation markers and by
mucus secretion (Costello et al., 2014a).
Inducing Villi/Crypt Organization
Other studies exploit scaffold technology for intestinal in vitro
models not necessarily to recreate the villi architecture, but
also to give cues to the cells to adopt a more in vivo-like
behavior. In this context, a recent investigation by Dosh et al.
aimed at investigating the potential of three different hydrogel
scaffolds to support the 3D culture of Caco-2 and HT29-MTX
cells and evaluate their ability to stimulate villi formation. Here,
the authors used alginate hydrogels and cells were cultured in
different set-ups as well as under static or dynamic conditions
for up to 21 days. Caco-2 cell viability was increased when
laid on the synthetic hydrogel scaffolds but diminished when
suspended within them. In contrast, HT29-MTX maintained
similar viability in both conditions. Furthermore, cells cultured in
and on alginate scaffolds formed multilayer spheroid structures,
whereas the cells layered on synthetic hydrogel scaffolds formed
villus-like structures (Dosh et al., 2017).
The studies by Wang et al. (2014, 2017) also explored
the recreation of the intestinal microenvironment for the
differentiation of cells. More recently, a micropatterned collagen
scaffold with a crypt-villus architecture and an adequate chemical
gradient promoted the formation of a stem/progenitor-cell zone
and supported cell migration along the crypt-villus axis (Wang
et al., 2017).
By means of a different methodology, Kim and Kim (2018)
developed an innovative process to print a human intestinal
villi model, using a cell-laden bioink. Interestingly, the structure
of the tissue was appropriately recreated, and the cells laid
by this process presented higher activity and expression of
differentiation markers with respect to the cells in the control
(seeded using the traditional method).
“Tube-Like” Scaffolds
With a different perspective and on a different scale, Chen
et al. established a 3D porous silk protein scaffolding system
comprising an engineered hollow lumen. The hollow channel of
the 3D scaffolds was used to house Caco-2 and HT29-MTX cells,
while the porous bulk space was used to culture primary human
intestinal myofibroblasts (H-InMyoFibs) embedded in a collagen
gel. This scaffold and respective cell culture tubular architecture
were shown to induce typical physiological responses by favoring
accumulation of mucous secretions on the epithelium, leading
to low oxygen tension in the lumen, and enabling interaction
with bacteria from the gut. Moreover, this 3D intestinal model
allowed maintenance of tissue function and cell phenotype for
months (Chen et al., 2015).
Continuing the work of Costello’s group on the PLGA
scaffolds previously mentioned in this section, Shaffiey et al.
investigated the growth and differentiation of intestinal cells
on a novel tubular configuration scaffold. This time, the
researchers used intestinal stem cells and tested the cell
responses both in vitro and in vivo (with implantation in animal
models). They report that the cells differentiated into crypt-villi
structures on the scaffold and its colonization was enhanced
by coculture with myofibroblasts, macrophages and probiotic
bacteria. Remarkably, the implanted scaffolds enhanced mucosal
regeneration in vivo (Shaffiey et al., 2016).
STRESSING (AND STRETCHING) THE
IMPORTANCE OF MECHANICAL CUES
FOR CELLS: BIOREACTORS
This section describes some examples of engineered systems for
mechanical stimulation of cells, with particular reference to the
intestine. Cell monitoring is also considered.
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Cells respond to mechanical stimulation in different ways,
depending on the type, magnitude, frequency and duration
of the stress applied. For instance, tensile and compressive
stresses are applied perpendicular to the surface of the cell
or 3D construct; shear stress is applied parallel to the cell
or 3D construct surface; while strains can be applied by
stretching an elastic cell substrate. To understand the effect
of certain physical forces and deformations on cell and
tissue behavior, physiologically relevant mechanical stimuli are
applied at the cell and tissue level using devices known as
bioreactors. These devices are purposely designed to control the
temporal, spatial and intensity profiles of the force parameter
(Lopez et al., 2008; Mattei et al., 2014).
Some techniques to study mechanotransduction phenomena
in cells in their physiological microenvironment include the
application of compression, tension, shear stress and hydrostatic
pressure. As a more recent approach, the response of individual
cells to mechanical stimuli has been explored. This research line
uses advanced devices that are able to apply nano or micro-scale
forces to individual cells or their constituents, such in the case of
atomic force microscopy and traction force microscopy (García
et al., 2007). Nevertheless, these very small-scale techniques
might not be suitable for studying or mimicking the dynamics
of a complex tissue and as such are beyond the scope of
this review.
To See Is to Believe: Monitoring
Advanced cell culture systems should allow the user to not
only perform cell culture, but also to track it. Non-destructive
and continuous readouts giving information on cell vitality
and function are highly desirable characteristics for a cell
culture bioreactor. Most biologists are dependent on visual
monitoring of cells, as this provides an immediate assessment
of morphology and cell numbers. Indeed, several devices for
this purpose are composed (totally or partially) of transparent
components (Cacopardo et al., 2019). Furthermore, since the
intestinal epithelium is a physiological barrier, is crucial to
assess the integrity and tightness of the epithelial cell monolayer
in in vitro cultures. One way to do that is by measuring
the trans-epithelial electrical resistance (TEER), which is the
electrical, ohmic resistance of the cell layer (Benson et al.,
2013). The higher the value of TEER, the more compact
and integral is the barrier, indicating well developed tight
cell-cell junctions which inhibit paracellular current flow.
The most popular TEER measuring system is the Epithelial
VoltOhmMeter EVOM (World Precision Instruments) that
comes with chopstick-shaped electrodes for measuring the TEER
in transwells. Due to the advent of more sophisticated cell
culture systems, over the years researchers have been developing
alternative measuring approaches that are adapted to different
kind of devices (in terms of scale and measuring method).
Of particular note is the transepithelial electrical impedance
(TEEI), which, like TEER, provides information on the low
frequency resistance associated with paracellular current flow as
well as the high frequency impedance of the cell barrier which is
related to transcellular membrane-mediated capacitive currents.
Interfacing or integrating a TEER or TEEI measurement systems
with cell culture devices that include the presence of dynamic
components (flow and motility) can be an extra challenge,
especially in the case of micro-fluidic bioreactors due to
their small volume and available space. Nevertheless, several
research groups have successfully fabricated fluidic systems for
intestinal in vitro models that allow electrical measurements in
different modalities, as discussed in some the cases illustrated in
section Flow.
Flow
Controlled shear stress has been applied to cell cultures through
different flow chambers, which use either peristaltic, pressure
driven or syringe pumps that apply a parabolic laminar flow
profile. When it comes to the systems developed to study the
intestinal phenomena, we can divide them in five major classes
as represented in Figure 5.
Hollow Fibers
Back in 1995, McBride et al. developed a bioreactor made of
hollow fiber cassettes (McBride et al., 1995), that was later
adapted in 1999 by the researchers to culture a cell line of
human intestinal cells. The goal was to study the effect of chronic
dietary or environmental toxin exposure. This set up allowed
the researchers to perform a long-term study, in contrast with
the acute toxic effect, back then usually verified in flask tissue
culture (Hanley et al., 1999). Several years later, the hollow
fiber bioreactor set-up is still applied to morphologically mimic
the human small intestinal lumen. In 2013, Deng and his
colleagues used porous hollow fibers of polyethersulfone (PES)
to culture Caco-2 and study their differentiation and function.
The study revealed an accelerated expression of Caco-2 cell
function, suggesting its ability to simulate the original tissue
microenvironment (Deng et al., 2013).
FIGURE 5 | The different classes of bioreactors and flow systems and some
of their technical specifications.
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Go With the Flow: Perfusion Systems
Often, bioreactors are used to improve the culture conditions
of primary cells, that are known for short survival times when
cultured on the classic static systems. In order to sustain in
culture intestinal organoids harvested from rats, Kim et al.
developed a perfusion bioreactor. The results confirmed the
survival of the cells seeded on the scaffolds and cultured
in the bioreactor for 2 days (Kim et al., 2007). A work
by Pusch et al., consisted in using decellularized porcine
jejunal segments co-cultured with Caco-2 cells and primary
human microvascular endothelial cells (hMECs) in a dynamic
bioreactor. Some of the data were comparable with classic
Caco-2 testing results, while some results demonstrated that
in the decellularized segments cultured in the bioreactor cells
resembled normal primary enterocytes and showed increased
permeability to tested substances, when compared with static
cultures (Pusch et al., 2011).
As mentioned in section Cell Scaffolds: Sustaining the Idea of
3D, Schweinlin and colleagues (Schweinlin et al., 2016) developed
organoids using SIS that differentiated after 7 days. Additionally,
the epithelial barrier function was tested under the effect of flow
and with the co-culture of sub-epithelial fibroblasts as well. It was
verified that the presence of the intestinal fibroblasts stabilized
the barrier integrity and that the dynamic culture in a perfused
bioreactor induced expression of differentiation markers on the
epithelial cells, indicating that such complete system can sustain
the culture of primary intestinal cells (Schweinlin et al., 2016).
The “Food Processor-Like”—Reactor Vessels
To better recreate the conditions of digestion, including even a
food matrix, a dynamic GIT model was conceived in 2005 by
Mainville et al (Mainville et al., 2005). It consisted of two reactors,
one simulating stomach conditions and the other simulating
the duodenal microenvironment, that would mimic the target
organs, so that the authors could understand the interactions
with the probiotics. The dynamic model was shown to better
represent the events during upper GIT transit than conventional
methods (Mainville et al., 2005). Six years later, Tompkins et al.
adapted this system to perform similar studies on the same
subject and were able to conclude that some probiotics should
be ingested at a specific time interval from the meal (Tompkins
et al., 2011).
Continuing with the theme of the research on probiotic
bacteria, a gastrointestinal tract simulator (GITS) bioreactor was
conceived by Sumeri et al. The system consisted of a fermentation
vessel equipped with diverse sensors and different pumps to
provide the flow of diverse fluids. The work established that such
GITS could be successfully used for evaluation of viability of
probiotics (Sumeri et al., 2008).
Millifluidic Chambers
Giusti et al. assessed a novel two-chamber millifluidic bioreactor
for the culture of intestinal epithelial cells. After analyzing
the fluidic dynamics and pressure gradients for different
combinations of flow rates using computational models, Caco-2
cells were cultured on the device until they fully differentiated.
The authors verified that the dynamic conditions led to an
increase in barrier integrity values and in expression of tight-
junction markers with respect to the static controls. Interestingly,
the permeability of the cell barrier to the tested compound was
higher in dynamic conditions, suggesting that the bioreactor
could be used to perform drug delivery and nanomaterial
toxicity studies on different barrier tissues (Giusti et al., 2014).
Recently, Cacopardo et al described the design and development
of a bioreactor with an integrated sensing system (embedded
biocompatible electrodes interfaced with an impedance meter)
that allowed for online TEER and TEEI measurements and the
results obtained supported the finding of Giusti et al. (Cacopardo
et al., 2019).
Microfluidic Devices
Microfluidic devices often designated “Organ-on-a-chips” are
a trend nowadays. They were originally developed using
technology adapted from semiconductor manufacturing and
generally hold chambers perfused with culture media and
colonized by cells. The cells are arranged to simulate tissue- and
organ-level physiology (Bhatia and Ingber, 2014).
In 2008 Kimura et al. developed a micro pumping system
on-chip. Caco-2 cells were cultured in the device for more
than 2 weeks. Perfusion and transport measurements (using
fluorescent compounds detected with an optical fiber system)
were conducted, targeting the micro bioreactor for applications
in toxicity testing and drug screening (Kimura et al., 2008).
In 2010, microfluidics was an established technology,
as shown by the works of Imura et al. (2009, 2010). The
authors developed a microchip-based system that mimicked
the intestine. The microdevice was mainly composed of
polydimethylsiloxane (PDMS) sheets, with microchannels
fabricated using photolithography techniques, and the flow was
regulated with a microsyringe pump. The results of absorption
tests run on cultured Caco-2 cells in the microchip were
consistent with those obtained using conventional methods,
suggesting the suitability of the new system (Imura et al., 2009).
In the following year, the same research group used the developed
microchip to integrate micromodels of tissues—a component for
the intestine (using Caco-2 cells) and another one for the liver
(using HepG2 cells). The authors tested the intestinal absorption,
hepatic metabolism, and bioactivity of different substances and
claimed the feasibility of the operations on their device, reducing
time and cell consumption compared to the classic in vitro assays
(Imura et al., 2010). Some years after, with a similar approach,
Bricks et al. joined cell culture inserts and microfluidic biochips
in a fluidic platform to study the interaction between intestine
and liver, using Caco-2 and HepG2, respectively. This work
revealed that the integrity, viability and metabolism of both cell
types were maintained and that the co-culture system allowed
for biotransformation of a tested compound (Bricks et al., 2014).
Addressing the need to monitor the integrity of the intestinal
epithelial barrier, some authors considered the measurement of
TEER in their microsystems. Shah et al fabricated a microdevice,
called HuMix, that served to study the host–microbe molecular
interactions in the gut. One of its versions was designed to
allow the insertion of a commercial chopstick style electrode
to measure the TEER (Shah et al., 2016). With the purpose
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of studying the permeability of substances across an intestinal
barrier, Tan et al fabricated a microfluidic device with two sets
of electrodes embedded in the chip. To perform the TEER
measurements in this device, the wires coupled to the electrodes
were connected to a multimeter (Tan et al., 2018).
Microfluidics systems can also be used to recreate more than
one organ, evolving into what we call body-on-chip designs,
as it is the case of the next example. A modular GI tract-liver
system by co-culture of primary human intestinal epithelial cells
and 3D liver micro-lobe like construct was conceived by Chen
et al for preclinical studies applications (Chen et al., 2018). In
these systems the intestinal cells differentiated into major cell
types of the native tissue and formed a monolayer displaying
TEER values comparable with physiological values. Additionally,
the permeability of the cell barrier obtained was compared to a
conventional permeability model using Caco-2 cell response for
drug absorption by measuring the uptake of standard substances.
Going Further With the Flow, Adding Architecture
Bringing together the presence of dynamic conditions and the
fabrication of structures to mimic the intestinal architecture
(in this case, crypts or villi), some authors have developed
highly sophisticated systems to recreate the microenvironment
of the epithelium.
Last year, Costello et al. developed in vitro artificial
small intestines. Essentially, a small intestinal bioreactor was
constructed using polymeric scaffolds that mimicked the 3D
architecture of the tissue. The data obtained from the TEER
measurements (since the device was interfaced with an EVOM)
indicated that the presence of flow induces characteristics of cell
barrier tightness which are closer to the physiological condition
with respect to static culture. An increase in cell proliferation was
also verified and the authors reported that some cell responses
varied according to different regions of the construct and
according to different tested flow rates (Costello et al., 2017).
Shim et al. (2017), integrated a collagen scaffold that
mimics the human intestinal villi [developed originally in (Sung
et al., 2011)] in a microfluidic device, where the absorptive
permeability of the epithelium (composed of Caco-2 cells) as
well as the activity of representative enzymes were determined.
As hypothesized, the results suggested that the combination
of fluidic stimulus and 3D structure can induce further
improvement in the physiological relevance of intestinal in
vitromodels.
Motility
As any other mechanical force, stretch can be an important
modulator of cell physiology. For more than 40 years researchers
have been developing systems to study cell/tissue stretching
effects (Leung et al., 1977) that rely on the application of static or
cyclic deformation to monolayers of cells cultured on deformable
membranes or 3D scaffolds.
These systems can vary in configuration, scale operation and
mechanism of actuation, and there are many categories into
which they can be grouped. One can divide them, for instance,
in in-plane stretch systems and out-of-plane stretch systems,
or even by the type of strains they provide: uniaxial, biaxial,
or equiaxial (often referred as radial, when stretching circular
shaped substrates) (Brown, 2000). Some versatile systems can
also provide compression and not only stretching, as in the
example of the in vitro model of the intestine using electroactive
polymers as an actuating cell culture membrane (Cei et al.,
2016). The most common types of strain applied in-plane are as
illustrated in Figure 6.
Indeed, different studies have shown that cyclic mechanical
stretch induces proliferation, increases tissue organization, and
enhances mechanical properties on several cell types, as it briefly
illustrated in the following section.
Engineering Peristalsis
When it comes to the intestine, the epithelium should be affected
by the repetitive deformation during peristaltic distension and
contraction and by the repetitive shortening of villi. In a notable
work by Basson et al. Caco-2 cells were cultured on an elastic
membrane and subjected to 10% strains (on average), applied
with vacuum induced out-of-plane deformation, and it was
verified that the cyclic strain stimulated proliferation. This
response was higher in the membrane periphery where strain
was maximal and, furthermore, it modulated the expression
of specific brush border enzymes. The authors concluded
that mechanically-induced strains at a physiological frequency
and magnitude enhanced proliferation and modulated the
differentiation of this cell line in an amplitude-dependent way
(Basson et al., 1996). Later, the molecular pathways that led
to the reported effects were investigated and the proteins PKC
and tyrosine kinase were pointed as regulators of intestinal
epithelium proliferation and brush-border enzyme activity upon
cyclic deformation (Han et al., 1998).
Using a rat in vivo model, Safford and his colleagues
suggested that mechanical tension induced intestinal growth.
Their results indicated that the applied mechanical tension led
to an increase in Paneth cells numbers, that caused proliferation
and reorganization of the mucosa and muscularis propria. In
addition, the increased intestinal length corresponded to an
increase of enzymatic activity, suggesting a potential augmented
absorption of the stretched bowels (Safford et al., 2005).
This time using an in silico model, more specifically a
computational intestinal organoid culture model, Buske et al.
studied the role of biomechanics on the stem cell niche formation
FIGURE 6 | Representation of typical strain fields applied to cells on flexible
membranes stretched in-plane.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 9 June 2019 | Volume 7 | Article 144
Costa and Ahluwalia Intestinal in vitro Model Engineering
in the gut. The researchers improved a previous computational
model of intestinal tissue (Buske et al., 2011) by adding a
flexible membrane that assigned a bending modulus to the
organoid surface. According to the test results, the proliferation
induced shape changes leading to the formation of crypt-like
domains. The spontaneous localized tissue curvature could be
contribute to the regulation of stem cell organization (Buske et al.,
2012), illustrating once more the effects of cell deformation on
tissue differentiation.
Back to in vitro models of Caco-2 cells, a more recent study
by Samak et al. explored the impact of cyclic stretch on tight
junction and adherens junction integrity. The results indicated
that due to activation of specific signaling pathways, those apical
cell junctions were disrupted, as supported by the re-organization
of the junction’s proteins and increased paracellular permeability
(Samak et al., 2014).
Currently, perhaps one of the most advanced in vitro models
of the human intestine is the “human gut-on-a-chip” by Kim
et al. It consists of a microfluidic device that contemplates both
the shear stress induced by fluid flow and the cell stretching
induced by a deformable membrane. The device is composed
of two microfluidic channels separated by a porous flexible
membrane coated with ECM that was seeded with Caco-2
cells. The microenvironment of the intestinal epithelium was
mimicked by using a medium flow at a rate of 30 µL h−1 that
produced a shear stress of 0.02 dyne cm−2 and by applying
cyclic uniaxial strain (10%; 0.15Hz) that imitated physiological
peristaltic motions. This system allowed for a quick polarization
of the epithelium that spontaneously grew into folds and formed
a high integrity barrier (Kim et al., 2012).
Later, this same system was used to co-culture commensal
microbes in contact with the intestinal epithelium cells. After 1
week, the authors report that immune cells and endoxins together
stimulated epithelial cells to produce proinflammatory cytokines
which can induce villus injury and compromise intestinal barrier
function. This showed that the chip can also be used to study
interaction between microbiome and intestinal pathophysiology
in a controlled environment (Kim et al., 2016).
More recently, Kasendra et al. (2018) developed a small
intestine-on-a-chip for culturing epithelial cells obtained from
intestinal biopsies that were previously expanded as 3D organoids
and then dissociated and culture on the porous membrane
of the chip in co-culture with human intestinal microvascular
endothelium. This device was conceived to provide both flow and
uniaxial cyclic deformation to the cells. The authors reported the
formation of villus-like projections lined by polarized epithelial
cells which differentiated similarly to the organoids in terms
of cell linages, but this time exposing their apical surfaces
to the lumen-like channels. Moreover, transcriptomic analysis
indicated that the chip closely mimicked the human duodenum
in vivo with respect to the precursor organoids.
DISCUSSION
In this paper we identified some of the key physical parameters
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epithelium and that are therefore desirable in an in vitro model.
A number of technologies and systems which recapitulate these
features are described and summarized in Table 2. As can be seen
from Table 2, many of them address a couple, or even several, of
the requirements for the “ideal intestinal in vitro model” (listed
in the Introduction and distilled in Table 1).
As the complexity of the biomimetic models increased,
they better approximated the in vivo tissue. For instance, as
mentioned in section Stressing (and Stretching) the Importance
of Mechanical Cues for Cells: Bioreactors, the model of gut-on-
a-chip by Kim et al. (2012) integrated the presence of fluid flow,
cyclic peristalsis-like movements, commensal microbes and the
presence of villi-like 3D structures (whose formation was induced
by the microenvironment). This device is indeed one of the
finest examples of the success of the organ-on-chip technologies.
However, since the chip only comprises one layer of the intestinal
wall, it is not enough to study phenomena such as inflammatory
diseases, that are modeled by the interaction with nervous and
immune systems cells (Vasina et al., 2006). In contrast, the work
by Kasendra et al. (2018) used a similar approach but pursued a
higher complexity at the cellular level, but then again, it did not
include the presence of the microbiota. One interesting aspect of
this work was the use of “disassembled organoids,” showing that
despite being a breakthrough in this field, organoids do possess
some limitations. Although one can have the representation
of all the cell types of the epithelium, the interactions with
non-parenchymal cells is still lacking. Furthermore, as seen
previously in section Cells, due to their architecture, the cells
cannot be exposed to mechanical stimuli and are not easily
available for drug transport studies (Fatehullah et al., 2016; Yin
et al., 2016). Nowadays, the microfluidics technology explored
in these two last examples is of great popularity, but it still has
a long road of improvement ahead, such as the standardization
protocols and eventually, the adaptation/integration into human-
on-a-chip systems for pharmacokinetic and pharmacodynamic
studies. Conversely, one might ask: is the microscale enough to
recreate the complexity of a tissue? Some authors prefer using
miniaturized bioreactors that deal with milli-fluidics, arguing
that microfluidic devices contain few functional units—groups of
cells which can mimic organ function at the micro-scale–thus,
they are not representative of a tissue. Additionally, microscaled
devices present “extremely high surface to volume ratio, which
gives rise to high wall shear stresses,” and prompt the “so-called
edge-effect, with a large portion of cells lying at the periphery of
the system and not interacting properly with the bulk of the cells”
(Mattei et al., 2014).
Indeed, the recreation of the microenvironment of the
cells is of major importance, as was underlined in section
3D Architecture. It is expected that emergent biofabrication
techniques will allow for the recreation of the complex
environment cues of the intestinal mucosa, by creating
heterogenous constructs with different biochemical gradients
for different cells (Malda et al., 2017). Another goal in the
tissue engineering field is the promotion of vascularization and
intestinal models are no exception. With an adequate blood
vessels network, the in vivo tissue can be better represented,
and appropriate supply of nutrients is ensured for the 3D cell
structures thicker than 100–200µm (Du et al., 2011).
So far, it seemed that the merging of all the presented
features in one single system was the best approach to obtain
more predictive outcomes from an intestinal in vitro model.
However, the question arises: is it really necessary? Or even
better: when is it necessary? The answers may vary, but it appears
to be consensual that the ideal features of a model depend on
its usage.
Certainly, the applications for tissue engineering require
different conditions compared to those required for other fields—
as was verified in the studies that started from a 3D cell organoid
and opted for a monolayer configuration n of the epithelium. The
3D architecture of a tissue is definitely desirable for regenerative
applications, ideally counting on the presence of constituents of
other layers of the mucosa as well. But it might not be ideal if
the scope of the study is to assess the permeability of a recently
discovered compound, for instance.
As a concluding remark, the design criteria of an intestinal
in vitro model depend on its application. Having identified the
application, a researcher should refer to the relevant physiological
parameters, such as those listed in Table 1 (when applicable) to
develop an appropriate model. Table 2 may be useful to identify
the most suitable tools that can be used to develop such models
focusing on their features and typical applications.
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